Literature DB >> 9805037

Discontinuation reactions associated with SSRIs.

L Macdonald.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9805037      PMCID： PMC1243875     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Who cares about pharmacovigilance?

Authors:  I R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.

Authors:  M M Stahl; M Lindquist; M Pettersson; I R Edwards; J H Sanderson; N F Taylor; A P Fletcher; J S Schou
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

3.  Time to act on drug safety.

Authors:  T J Moore; B M Psaty; C D Furberg
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

4.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

Review 5.  Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.

Authors:  A F Schatzberg; P Haddad; E M Kaplan; M Lejoyeux; J F Rosenbaum; A H Young; J Zajecka
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 6.  Clinical management of antidepressant discontinuation.

Authors:  J F Rosenbaum; J Zajecka
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 7.  Newer antidepressants and the discontinuation syndrome.

Authors:  P Haddad
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

8.  Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.

Authors:  L Frost; S Lal
Journal:  Am J Psychiatry       Date:  1995-05       Impact factor: 18.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.